- Home
- ASTC vs ATHA Comparison
ASTC vs ATHA Comparison
Compare ASTC & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- ATHA
- Stock Information
- Founded
- ASTC 1984
- ATHA 2011
- Country
- ASTC United States
- ATHA United States
- Employees
- ASTC N/A
- ATHA N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- ASTC Industrials
- ATHA Health Care
- Exchange
- ASTC Nasdaq
- ATHA Nasdaq
- Market Cap
- ASTC 9.8M
- ATHA 10.6M
- IPO Year
- ASTC 1995
- ATHA 2020
- Fundamental
- Price
- ASTC $5.63
- ATHA $0.42
- Analyst Decision
- ASTC
- ATHA Buy
- Analyst Count
- ASTC 0
- ATHA 4
- Target Price
- ASTC N/A
- ATHA $11.25
- AVG Volume (30 Days)
- ASTC 8.4K
- ATHA 248.6K
- Earning Date
- ASTC 05-13-2025
- ATHA 07-31-2025
- Dividend Yield
- ASTC N/A
- ATHA N/A
- EPS Growth
- ASTC N/A
- ATHA N/A
- EPS
- ASTC N/A
- ATHA N/A
- Revenue
- ASTC $903,000.00
- ATHA N/A
- Revenue This Year
- ASTC N/A
- ATHA N/A
- Revenue Next Year
- ASTC N/A
- ATHA N/A
- P/E Ratio
- ASTC N/A
- ATHA N/A
- Revenue Growth
- ASTC N/A
- ATHA N/A
- 52 Week Low
- ASTC $5.39
- ATHA $0.22
- 52 Week High
- ASTC $12.29
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- ASTC 45.41
- ATHA 73.73
- Support Level
- ASTC $5.52
- ATHA $0.29
- Resistance Level
- ASTC $5.73
- ATHA $0.32
- Average True Range (ATR)
- ASTC 0.25
- ATHA 0.03
- MACD
- ASTC -0.01
- ATHA 0.01
- Stochastic Oscillator
- ASTC 16.96
- ATHA 78.16
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.